Protagonist Therapeutics Inc (PTGX)
Operating Cash Flow Growth
861.13%
Quarterly · Period ending:
PTGX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported861.13%period ending
Latest reported861.13%period ending
PTGX Quarterly Cash from Operations YoY % (-115.33% → 861.13%)
Year-over-year change
High-resolution chart · PNG
PTGX operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 861.1258% | |
| -139.041% | |
| -26.7222% | |
| 93.0481% | |
| -110.7139% | |
| 557.0455% | |
| -272.0401% | |
| -4.7048% | |
| 1,123.7899% | |
| 20.1415% | |
| 153.6115% | |
| -5.595% | |
| -92.4312% | |
| 8.8117% | |
| -17.432% | |
| 11.4823% | |
| 42.4684% | |
| -30.9848% | |
| -42.7837% | |
| -74.802% | |
| -10.3249% | |
| -81.4488% | |
| -32.0386% | |
| -14.3268% | |
| -685.3406% | |
| 4.8854% | |
| -40.9867% | |
| -53.5791% | |
| 123.8343% | |
| -10.0674% | |
| 28.3695% | |
| -122.7889% | |
| -24.9128% | |
| -46.1761% | |
| -46.1674% | |
| 683.1519% | |
| -52.6942% | |
| -97.6713% | |
| -104.2625% | |
| -85.195% | |
| -134.4077% | |
| -115.3309% |